Table 2

Study population with two balanced study groups after propensity score matching

Colchicine (−)
(N=73)
Colchicine (+)
(N=73)
P value
Gender, n (%)
 Female19 (26)19 (26)1.00
 Male54 (74)54 (74)
Age, mean (SD)46.7 (20.2)48.0 (21.2)0.62
Cardiovascular risk factors, n (%)42 (58)40 (55)0.74
Idiopathic/viral, n (%)66 (90)62 (85)0.35
Fever, n (%)39 (54)31 (42)0.15
HR≥70, n (%)52 (71)45 (62)0.25
ST-segment elevation, n (%)31 (42)22 (30)0.08
EF>55%, n (%)59 (81)60 (82)0.83
PE, n (%)24 (33)35 (48)0.07
CRP (mg/dL), mean (SD)55.4 (53.8)59.7 (61.9)0.87
CRP>5, n (%)67 (92)62 (85)0.13
Myocardial oedema on CMR, n (%)16 (22)16 (22)1.00
Myocardial LGE on CMR, n (%)28 (38)35 (48)0.22
NSAIDs, n (%)68 (93)63 (86)0.16
Corticosteroids, n (%)15 (21%)16 (22%)0.83
  • CMR, cardiac magnetic resonance; CRP, C reactive protein; EF, ejection fraction; HR, heart rate; LGE, late gadolinium enhancement; NSAIDs, non-steroidal anti-inflammatory drugs; PE, pericardial effusion.